Eledon's Type 1 Diabetes Cure: What's Fact and What's Fiction?

0:00-1:13:54

Send us Fan Mail We can be excited and practical at the same time. It's important to look beyond the headlines at the specific challenges within any clinical trial aiming to cure type 1 diabetes. Recently, I've been accused of "smearing" the Eledon study because I've explained that—even though the results are extraordinary—this therapy is still a long way from becoming a cure that's available to thousands, let alone millions, of people living with type 1 diabetes. So today, I sat down with someone who knows this therapy better than almost anyone: Katie Beth Hand (Find her on Instagram: https://www.instagram.com/calamitykatiebeth/) Katie Beth is one of the participants in the University of Chicago study using Eledon's anti-rejection drug, tegoprubart, alongside transplanted islet cells. She's currently living insulin-free because of that treatment. In this conversation, we talk about what life is actually like after transplant, what the therapy involves, the benefits, the limitations, the business behind a clinical trial, and why it's important to be both excited and realistic about where this research stands today. You don't have to choose between hope and honesty. We can have both. Watch the interview and decide for yourself. Other interviews I've done with Eledon study participants: Katie Beth - 1 month post-transplant Katie Beth - 3 months post-transplant Chris Pacheco - 4 months post-transplant The Problem with Eledon's Cure for T1D Thanks for tuning in!

Publisher

Diabetes Nerd

Published

June 22, 2026

Duration

1h 14m

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

DN

Diabetes Nerd

@diabetesnerd

#eledonstype #diabetescure #whatsfiction #medicine #selfimprovement

The Nile